Shares of Co-Diagnostics, Inc. (CODX) are up more than 5% in the morning trade on Monday at $6.29.
The molecular diagnostics company today said it has shipped testing reagents for monkeypox virus to one of its international distributors.
As of July 7, 2022, over 6,000 cases of monkeypox have been reported to WHO from 59 countries, the company said.
CODX has traded in the range of $3.66-$11.82 in the past 52 weeks.
Source: Read Full Article
Lates News:
-
Bitcoin Price Now 'Well-Positioned' to Hit $48,000 This Month if This Pattern is Maintained
-
Why Vitalik Buterin Is ‘Actually Kinda Happy a Lot of the ETFs Are Getting Delayed’
-
Axonics Increases 11% As Q4 Prel. Revenue Better Than View
-
Crypto Analyst Alex Krüger on Bitcoin Price: ‘30K-35K Looks Very Doable’
-
Longeveron Rallies 20% In Morning Trade